Aurelien Amiot

41PUBLICATIONS
86CO-AUTHORS
Immunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsOrganic and low chemical input crop productionApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (41)

|May 12, 2026
Comparative risk of serious infection in patients with ulcerative colitis treated with JAK inhibitors.

|Apr 27, 2026
One-Year Effectiveness of Upadacitinib in Perianal Crohn's Disease: A Real-World GETAID Study.

|Feb 26, 2026
Histogenetic Classification Predicts Outcomes in 130 Adults With Chronic Intestinal Pseudo-Obstruction.

Minh-Chau Ta, Dominique Cazals-Hatem, Lore Billiauws

|Jun 24, 2025
Fruits, Vegetables, Legumes, and Potatoes and Risk of Crohn's Disease and Ulcerative Colitis.

Antoine Meyer, Franck Carbonnel, Christina C Dahm

|Nov 25, 2024
Top-down infliximab plus azathioprine versus azathioprine alone in patients with acute severe ulcerative colitis responsive to intravenous steroids: a parallel, open-label randomised controlled trial, the ACTIVE trial.

Aurelien Amiot, Philippe Seksik, Antoine Meyer

|Nov 02, 2024
Impact of Histological Remission for Predicting Clinical Relapse in Crohn's Disease: A Post Hoc Analysis of the Prospective STORI Cohort.

Catherine Reenaers, Diana Enea, Marie Nachury

Pageof 7

Frequent Collaborators

11 joint publications

Anthony Buisson

11 joint publications

Guillaume Bouguen

11 joint publications

David Laharie

9 joint publications

Laurent Peyrin-Biroulet